Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

• Rebecca Craig-Schapiro,

  Affiliation Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Max Kuhn,

  Affiliations Neuroscience Research Unit, Pfizer Global Research and Development, Groton, Connecticut, United States of America, Neuroscience Research Unit, Pfizer Global Research and Development, St. Louis, Missouri, United States of America

  ⨯
• Chengjie Xiong,

  Affiliations The Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Eve H. Pickering,

  Affiliations Neuroscience Research Unit, Pfizer Global Research and Development, Groton, Connecticut, United States of America, Neuroscience Research Unit, Pfizer Global Research and Development, St. Louis, Missouri, United States of America

  ⨯
• Jingxia Liu,

  Affiliation Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Thomas P. Misko,

  Affiliations Neuroscience Research Unit, Pfizer Global Research and Development, Groton, Connecticut, United States of America, Neuroscience Research Unit, Pfizer Global Research and Development, St. Louis, Missouri, United States of America

  ⨯
• Richard J. Perrin,

  Affiliations The Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Division of Neuropathology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Kelly R. Bales,

  Affiliations Neuroscience Research Unit, Pfizer Global Research and Development, Groton, Connecticut, United States of America, Neuroscience Research Unit, Pfizer Global Research and Development, St. Louis, Missouri, United States of America

  ⨯
• Holly Soares,

  Affiliations Neuroscience Research Unit, Pfizer Global Research and Development, Groton, Connecticut, United States of America, Neuroscience Research Unit, Pfizer Global Research and Development, St. Louis, Missouri, United States of America

  ⨯
• Anne M. Fagan,

  Affiliations Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America, The Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• David M. Holtzman

  * E-mail: holtzman@neuro.wustl.edu

  Affiliations Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America, The Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯